Clinical Trials Logo

Retinal Disease clinical trials

View clinical trials related to Retinal Disease.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06173414 Completed - Healthy Clinical Trials

Adaptive Optics ScanningLaser Ophthalmoscope Safety and Efficacy Clinical Trial

Start date: July 5, 2023
Phase:
Study type: Observational

This prospective, multicenter, single-group, target-value clinical trial was designed to evaluate the efficacy and safety of an Adaptive Optics ScanningLaser Ophthalmoscope(AOSLO) for ophthalmic examination.

NCT ID: NCT05664555 Completed - Retinal Disease Clinical Trials

Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)

DOSE
Start date: February 1, 2023
Phase: Phase 4
Study type: Interventional

This study aims to compare the efficacy and safety of fluorescein angiography using 1mL versus 3mL of 10% fluorescein dye.

NCT ID: NCT05416268 Completed - Retinal Disease Clinical Trials

Study to Compare the Diopsys NOVA and LKC RETeval Devices

Start date: May 4, 2022
Phase: N/A
Study type: Interventional

To compare the Diopsys NOVA and LKC RETeval Devices using the Diopsys Lid Electrodes and LKC RETeval Self-Adhering Electrode Arrays.

NCT ID: NCT04945772 Completed - Clinical trials for Retinitis Pigmentosa

Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]

RESTORE
Start date: July 13, 2021
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy of a single intravitreal injection of virally-carried Multi-Characteristic Opsin (MCO-010).

NCT ID: NCT04919473 Completed - Clinical trials for Retinitis Pigmentosa

Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa

Start date: October 23, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to evaluate the safety and tolerability of a single intravitreal injection of virally-carried Multi-Characteristic Opsin I (vMCO-I)

NCT ID: NCT04912622 Completed - Retinal Disease Clinical Trials

RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders

CEL01LUKS
Start date: May 19, 2021
Phase: N/A
Study type: Interventional

Accumulating evidence suggest that the functional unit of photoreceptor/ retinal pigment epithelium (RPE)/Bruch's membrane/choriocapillaris plays a key role in pathophysiologic processes of a wide range of medical retinal disorders of the eye. Little is known about in vivo morphometric characteristics of human RPE cells as in vivo observation of these cells was so far technically challenging and hence nearly impossible to implement in a clinical setting. Transscleral optical phase imaging is a novel in-vivo microscopy technique allowing human RPE imaging on a cellular level with the potential of clinical application in a multimodal retinal imaging approach for diagnostic purpose in medical retina patients.

NCT ID: NCT04902170 Completed - High Myopia Clinical Trials

Long-shaft Vitrectomy Probe in Highly Myopic Eyes

Start date: July 22, 2021
Phase: N/A
Study type: Interventional

This study aimed to compare the safety and efficacy of vitrectomy probe with different shaft lengths in vitreoretinal surgery of highly myopic patients. In this randomized controlled study, highly myopic patients who had axial length more than 26 mm and needed vitreoretinal surgery will be enrolled. The enrolled patients will be randomized into "30 mm shaft length group"(trial group) and "27mm shaft length group"(controlled group). We will compare the rate of wound leakage, hypotony, subconjunctival hemorrhage, probe bending, trocar removal, and endophthalmitis between the two groups. We would like to evaluate the efficacy and safety of the 30 mm shaft length vitrectomy probe.

NCT ID: NCT04891211 Completed - Clinical trials for Vitamin D Deficiency

Retinal Changes in Vitamin D Deficiency

VDD
Start date: February 12, 2021
Phase: N/A
Study type: Interventional

Retinal tissue parameters of pediatric patients with vitamin D deficiency will be evaluated in this prospective case-control study. The patients will be divided into 2 groups according to the vitamin D level. Retinal vessel diameters, retinal nerve fiber evaluation, choroidal thickness will be evaluated. Choroidal thinning decrease in retinal artery diameter and increase in retinal vein diameter will be detected in the vitamin D deficiency group.

NCT ID: NCT04678375 Completed - Clinical trials for Artificial Intelligence

Artificial Intelligence for Detecting Retinal Diseases

Start date: June 1, 2018
Phase:
Study type: Observational

The objective of this study is to apply an artificial intelligence algorithm to diagnose multi retinal diseases from fundus photography. The effectiveness and accuracy of this algorithm was evaluated by sensitivity, specificity, positive predictive value, negative predictive value, and area under curve.

NCT ID: NCT04398394 Completed - Retinal Disease Clinical Trials

Retinal Imaging With Oblique Illumination

ASSESS
Start date: August 11, 2020
Phase: N/A
Study type: Interventional

Retinal diseases are the major cause of blindness in industrialized countries and while tremendous effort is made to develop novel therapeutic strategies to rescue retinal cells, optimal means to evaluate the effects of such treatments is still missing. Nowadays, diseases diagnosis and treatment monitoring are performed thanks to imaging devices and functional measurements (visual acuity of visual field tests). These eye examinations lead to the detection of large scale damages of the retinal tissue, i.e. the diagnosis is made too late or the treatments cannot be adapted in time. With the developed technology, the goal is to provide a tool to the ophthalmologists that allow for better treatment monitoring and early diagnosis. Indeed, the technology is able to image the retinal tissues with a ten times more detailed visualization as compared to the standard of care (OCT instruments, SLO instruments or eye fundus cameras). Towards this goal, we designed the present protocol in order to test the technology with a clinical prototype (Cellularis version 1) in a clinical environment. The objective is to describe and quantify at the cellular level the retina of patient affected by different retinal diseases as well as the healthy retina of people with different ages. We will assess the repeatability of the instrument and compare the results of the measurements with images obtained with the standard of care (OCT and SLO images).